The cloud-based software company is hiring like crazy in an effort to drive its next phase of growth.
Unexpected costs are hitting the government software provider's bottom line hard.
Shares rise after the company receives some praise from a pair of Wall Street analysts.
Traders knock down the stock in response to an analyst downgrade.
The medical device maker's first earnings report as a public company featured explosive revenue growth and upbeat full-year guidance.
Medical devices can be ultra reliable, lucrative business, but there are plenty of ways for companies to blow it, too.
Traders bid up the stock in response to another strong earnings report.
The cybersecurity company reported good first-quarter results but stated that its business momentum is slowing down.
The company is winning its fair share of new business, but some big projects are taking a long time to come to fruition.
First-quarter results looked good, but the company's guidance left investors wanting more.
Shares fall hard after the company reported mixed first-quarter results and issued weak guidance.
The software-as-a-service business is sacrificing near-term profit growth in an effort to maximize revenue growth.
The stock sinks after the medical device marker slashes its full-year guidance.
Shares jump even though its first-quarter results fell short of Wall Street's estimates. What can explain the optimism?
Shares fall hard after the company reports rough first-quarter results and announces a leadership transition.
Management talks about international expansion, potential FDA approval, and Medicare reimbursement.
The medical-device maker continues to roll out new products and grab market share.
Management's decision to play the long game is weighing on near-term revenue and profit growth.
Shares drop after the company reports first-quarter results that missed the mark.
First-quarter results missed the mark, but traders are feeling upbeat because this company's backlog continues to grow.